- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 187 Pages
Global
From €3450EUR$3,939USD£2,994GBP
Oxytetracycline is an antibiotic used to treat a wide range of bacterial infections. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Oxytetracycline is commonly used to treat respiratory infections, urinary tract infections, skin infections, and sexually transmitted diseases. It is also used to treat acne and rosacea. Oxytetracycline is available in both oral and injectable forms.
The market for Oxytetracycline is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Other companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals also offer Oxytetracycline products. Show Less Read more